Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients

In this online educational program CCO’s expert faculty explore optimal care for patients with AML including predictive/prognostic factors to consider in selecting treatment for AML management of newly diagnosed AML treatment of relapsed/refractory disease and novel agents that may affect care in the near future.

Share

Program Content

Activities

CPX-351 in AML
How Newly Approved CPX-351 Will Change AML Treatment
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: September 28, 2017

Expires: September 27, 2018

New Targeted Agents in AML
How I Use New Targeted Agents to Improve Outcomes for My Patients With AML
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 12, 2017

Expires: October 11, 2018

AML Treatment Changes
My Top Picks for AML Abstracts in Atlanta
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2017

Expires: November 19, 2018

Activities

AML Therapeutic Progress
Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 31, 2018

Expires: January 30, 2019

Activities

AML Clinical Trials
Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients: Clinical Trial Guide
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 05, 2017

Expires: December 04, 2018

AML Diagnostic Testing
Progress in Acute Myeloid Leukemia: Adapting Treatment to Individual Patients: Diagnostic Testing Guide
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2017

Expires: December 06, 2018

Activities

AML Diagnostic Testing
Expanding the Information Needed to Make the Most Informed Treatment Decisions in AML: Downloadable Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 12, 2017

Expires: December 11, 2018

Newly Diagnosed AML
Managing Newly Diagnosed AML: Treatment Considerations to Personalize Care: Downloadable Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2017

Expires: December 12, 2018

Relapsed/Refractory AML
Current Management of Relapsed Acute Myeloid Leukemia
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2017

Expires: December 12, 2018

AML: Emerging Agents
Integrating Emerging Targeted Therapies Into AML Treatment Strategies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 13, 2017

Expires: December 12, 2018

Faculty

cover img faculity

Jeffrey E. Lancet, MD

Senior Member & Professor
Chair,
 Department of Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

cover img faculity

Gail J. Roboz, MD

Associate Director of the Leukemia Program
Assistant Professor of Medicine
Weill Medical College
Cornell University

cover img faculity

Roland B. Walter, MD, PhD, MS

Associate Member, Clinical Research Division
Fred Hutchinson Cancer Research Center
Associate Professor of Medicine
Division of Hematology
Department of Medicine
University of Washington School of Medicine
Adjunct Associate Professor 
Departments of Pathology and Epidemiology
University of Washington School of Public Health
Seattle, Washington

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Astellas Text

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals Inc

Pfizer, Inc.